Relatlimab and nivolumab in the treatment of melanoma

Au, L; Larkin, J; Turajlic, S

Turajlic, S (通讯作者)，Francis Crick Inst, Canc Dynam Lab, London NW1 1AT, England.;Larkin, J; Turajlic, S (通讯作者)，Royal Marsden NHS Fdn Trust, Renal & Skin Units, London SW3 6JJ, England.;Larkin, J; Turajlic, S (通讯作者)，Inst Canc Res, Melanoma & Kidney Canc Team, London SW7 3RP, England.

CELL, 2022; 185 (26): 4866

Abstract

Combined LAG-3 and PD-1 blockade is an emerging strategy for the treatment of melanoma. Tawbi et al. and Amaria et al. report in The New England Journ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索